Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 16/20 | 0.62 |
| ▸ | INSR | P06213 | 3/20 | 0.54 |
| ▸ | IGF1R | P08069 | 3/20 | 0.54 |
| ▸ | ALK | Q9UM73 | 3/20 | 0.54 |
| ▸ | MET | P08581 | 1/20 | 0.51 |
| ▸ | AXL | P30530 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26906906 | 1.00 | EGFR (0.62) | EGFRINSRIGF1RALKMET | |
| SCHEMBL26906985 | 0.91 | EGFR (0.51) | EGFRINSRIGF1RALK | |
| SCHEMBL26906574 | 0.87 | EGFR (0.53) | EGFRINSRIGF1RALKMET | |
| SCHEMBL29904687 | 0.87 | EGFR (0.53) | EGFRINSRIGF1RALKMET | |
| SCHEMBL26906731 | 0.85 | EGFR (0.65) | EGFRINSRIGF1RALKMET | |
| SCHEMBL26906955 | 0.84 | EGFR (0.61) | EGFRINSRIGF1RALK | |
| SCHEMBL29904632 | 0.84 | ALK (0.71) | EGFRINSRIGF1RALKMET | |
| SCHEMBL26906765 | 0.84 | ALK (0.71) | EGFRINSRIGF1RALKMET | |
| SCHEMBL26906554 | 0.84 | EGFR (0.68) | EGFRINSRIGF1RALK | |
| SCHEMBL26906702 | 0.83 | EGFR (0.65) | EGFRINSRIGF1RALK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022211573-A1 | PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 테라펙스 | 2022-10-06 | — | — | WO | claimed |
| WO-2022211573-A1 | PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME | 주식회사 테라펙스 | 2022-10-06 | — | — | WO | disclosed |